PTC Therapeutics, Inc. (PTCT) Total liabilities 2016–2025
PTC Therapeutics, Inc. (PTCT) total liabilities at each fiscal year-end, per SEC filings.
$3.1BFY2025 · since FY2016: $149.8M → $3.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.1B | +10.7% |
| FY2024 | $2.8B | +3.3% |
| FY2023 | $2.7B | +32.2% |
| FY2022 | $2.1B | +6.0% |
| FY2021 | $1.9B | +12.2% |
| FY2020 | $1.7B | +67.7% |
| FY2019 | $1.0B | +34.0% |
| FY2018 | $768.5M | +226.7% |
| FY2017 | $235.2M | +57.1% |
| FY2016 | $149.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice